FDA conditionally approves QYLEKI as brand name for Quoin drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. AAPL
6. TRMD
7. ONON
8. AZN
9. BETR
10. NVDA

Go back to FDA conditionally approves QYLEKI as brand name for Quoin drug
(NASDAQ: QNRX) Delayed: 7.05 +0.04 (0.57%)
Previous Close $7.01    52 Week High $ 
Open $6.85    52 Week Low $ 
Day High $7.13    P/E N/A 
Day Low $6.70    EPS $ 
Volume 11,247